Moreover, rEPO treatment failed to induce the tyrosine phosphorylation of JAK2 or STAT5 in mammary carcinoma cells (figure 6A), even following longer time-course stimulation of the cells with rEPO (data not shown). The gene discussed is JAK2; the disease is breast carcinoma.